Originally published In Press as doi:10.1074/jbc.M206422200 on September 30, 2002
J. Biol. Chem., Vol. 277, Issue 50, 48993-49002, December 13, 2002
Characterization of a First Domain of Human
High Glycine-Tyrosine and High Sulfur Keratin-associated
Protein (KAP) Genes on Chromosome 21q22.1*
Michael A.
Rogers
§¶,
Lutz
Langbein§
,
Hermelita
Winter
,
Claudia
Ehmann
,
Silke
Praetzel
, and
Jürgen
Schweizer
From the
Section of Normal and Neoplastic Epidermal
Differentiation and
Division of Cell Biology, German Cancer
Research Center, 69120 Heidelberg, Germany
Received for publication, June 28, 2002, and in revised form, September 9, 2002
 |
ABSTRACT |
Analysis of the
EBI/GeneBankTM data base using non-human hair
keratin-associated protein (KAP) cDNA sequences as a query resulted in the identification of a first domain of high glycine-tyrosine and
high sulfur KAP genes located on human chromosome 21q22.1. This domain,
present on the DNA accession numbers AP001078 and AP001709, was ~535
kb in size and contained 17 high glycine-tyrosine and 7 high sulfur KAP
genes, as well as 9 KAP pseudogenes. Based on amino acid sequence
comparisons of the encoded proteins, the KAP genes could be divided
into seven high glycine-tyrosine gene families (KAP6-KAP8, and
KAP19-KAP22) and four high sulfur gene families (KAP11, KAP13, KAP15,
and KAP23). The high glycine-tyrosine genes described here appear to
represent the complete set of this type of KAP genes present in the
human genome. Both systematic cDNA isolation studies from an
arrayed scalp cDNA library and in situ hybridization
expression studies of all of the KAP genes identified in the 21q22.1
region revealed varying degrees and regions of expression of 11 members
of the high tyrosine-glycine genes and 6 members of the high sulfur KAP
genes in the hair forming compartment.
 |
INTRODUCTION |
The hair follicle represents one of the few organs of the body
that, throughout life, undergoes alternating cycles of growth, senescence, and rest (1). Morphologically, the hair follicle is
composed of external epithelial compartments, the outer and inner root
sheaths, the companion layer, and a central hair fiber-forming (trichocytic) compartment, comprising the matrix, cuticle, and cortex.
Occasionally, a centrally lying medulla is present in specific hair
types. Growth of the hair originates in matrix cells located in the
bulb of the hair follicle. This hair bulb surrounds a dermal fibroblast
condensate, termed the dermal papilla, which is important for hair
follicle morphogenesis (1). The main structural proteins of the hair
fiber are the hair keratins and the hair keratin-associated proteins,
KAPs,1 the latter being
encoded by a large number of multigene families (2). Hair keratins, a
subset of the large keratin family whose members are found in all cells
of epithelial origin (3, 4), represent two multigene families, the type
I (acidic) and type II (basic) families that comprise 15 members in
humans (5, 6). They form the 8-10-nm intermediate filaments of
trichocytes by co-polymerization of type I and type II members, which
are differentially expressed during hair fiber development (7, 8).
KAPs, which form the matrix between the hair keratin intermediate filament bundles through extensive disulfide bond cross-linking with
cysteine residues in the head and tail domains of hair keratins, possess either high cysteine or high glycine-tyrosine content (2) and
are further divided into three broad groups containing, to date 17 families. These are the high sulfur families KAP1-KAP3 and
KAP10-KAP16, which contain less than 30 mol % cysteine (9-20), the
ultra-high sulfur families KAP4, KAP5, KAP9, and KAP17, with more than
30 mol % cysteine (20-26), and the high glycine-tyrosine KAP families
KAP6-KAP8 (27-30), which can be further divided into families with
high (>60 mol %, KAP6 family) and lower (< 60 mol %, KAP7 and KAP8
families) glycine-tyrosine content. The majority of the KAP members
were initially identified in non-human species (sheep, mouse, rabbit).
Recently, however, a large domain of human ultra-high/high sulfur KAP
gene families (the KAP1-KAP3, KAP4, KAP9, KAP16, and KAP17
families) have been identified on chromosome 17q21.2 and their
expression in the hair follicle partially characterized (20, 31).
Moreover, chromosomal in situ hybridization studies using
specific probes derived from human KAP5 family members have located new
KAP genes to chromosomes 11p15 and 11q13 (32). In addition, the
sequencing of human chromosome 21 has recently led to the
identification of a further KAP gene domain on its long arm (21q23)
(33). In a continuation of our previous KAP gene studies (20), we
describe here the identification of a novel domain of 24 KAP genes (17 high glycine-tyrosine and 7 high sulfur KAP genes) and 9 KAP
pseudogenes on chromosome 21q22.1. The genes could be grouped into 11 families, five of which are novel. Screening of a human scalp cDNA
library as well as mRNA expression studies showed the expression of
17 individual KAP members, all of which were essentially localized to
the hair cortex and several which also showed matrix and cuticular expression.
 |
MATERIALS AND METHODS |
Identification of Hair KAP Genes--
Analysis of the
EBI/GeneBankTM data base with DNA sequences from regions
encoding previously described KAP genes/cDNAs (KAP6-KAP8; KAP10-KAP15 family members) using the BLASTN2 program led to the discovery of a contiguous domain of KAP genes on the human
EBI/GeneBankTM data base sequences AP001708 and AP001709
(Fig. 1). Further DNA homology analysis using the program SIMILARITY
led to the identification of 33 putative gene/pseudogene loci. Genes
with open reading frames that showed high homology to KAP genes from other species were translated into protein sequences and multalignments made with known KAP family members using the CLUSTAL program. Evolutionary tree analysis of these proteins was performed using the
CLUSTREE program. Identification of putative amino acid repeat structures was made using the program DOTPLOT. All of the programs named above are part of the Heidelberg Unix Sequence Analysis Resource.
Isolation of KAP cDNAs--
3'-noncoding region PCR
fragments from each putative KAP gene were amplified from human
genomic DNA (see Table I) and used to
screen an arrayed human scalp cDNA library by procedures described previously (20). Briefly, the arrayed cDNA library was screened using 5× SSC, 5× Denhardt's solution, 0.1% sodium pyrophosphate, 1% SDS as prehybridization/hybridization buffer. 1 × 106 cpm/ml of hybridization solution of the respective
32P-labeled PCR fragment (see Table I) was used as a probe.
The library was hybridized overnight at 59 °C. Posthybridization
washes were performed three times using 0.5× SSC, 1% SDS at
59 oC for 30 min. The filters were autoradiographed using
Kodak XAR5 film (Amersham Biosciences). The isolated cDNA
clones can be obtained from either the authors or from the German Human
Genome Resource Center (RZPD) under the clone designations indicated in
Table I.
View this table:
[in this window]
[in a new window]
|
Table I
Primers used for the generation of KAP cDNA screening and in
situ hybridization probes and the accession numbers of the
isolated cDNAs
The accession numbers shown in bold type were full-length cDNA
sequences. DSP, did not screen positive; NF, screened positive, but
cross-hybridized with another KAP cDNA.
|
|
Automated DNA Sequencing--
The isolated cDNA clones were
sequenced using fluorescent dye terminator cycle sequencing (Big Dye
DNA Sequencing Kit, Applied Biosystems, Weiterstadt, Germany) and
analyzed on an ABI310 capillary DNA Sequencing Apparatus. DNA sequence
assembly and correction was performed using the STADEN software package
(Heidelberg Unix Sequence Analysis Resource).
In Situ Hybridization (ISH)--
ISH on cryostat sections of
human scalp (kindly provided by B. Cribier, Strasbourg, France) and, in
parallel, plucked beard hair follicles, were performed as described
previously (34, 35) using the PCR products shown in Table I, which were
subcloned into the pCR4.1 plasmid vector (Invitrogen). Antisense
35S-labeled transcripts of all of these subclones were used
for the detection of the respective KAP mRNA species as described previously (8, 34). The ISH signals were visualized using a confocal
laser scanning microscope (LSM 510; Carl Zeis, Jena, Oberkochen,
Germany). Simultaneous visualization of reflected ISH signals through
epi-illumination and transmitted light in bright field were combined by
overlay using pseudocolors (transmission image in green, electronically
changed to black/white; reflection image (ISH signal) shown in red).
 |
RESULTS |
KAP Gene Identification--
Our recent detection of a
high/ultra-high sulfur KAP gene domain on chromosome 17 led us to look
further for human orthologs of the high glycine-tyrosine KAP gene
families, KAP6-8, previously described in other species (27-30). This
resulted in the discovery of a putative KAP gene domain on chromosome
21q22.1, a region not previously identified during the sequencing of
this chromosome (33). We undertook a thorough DNA homology analysis and
identified two contiguous genomic DNA sequences, AP001708 and AP001709, on chromosome 21q22.1, which harbored 24 high glycine-tyrosine and high
sulfur KAP genes as well as 9 KAP pseudogenes (Fig.
1). The KAP gene domain analyzed covered
an area of 535 kb straddling one end of both genomic sequences. All KAP
genes possessed a methionine start codon and an open reading frame
coding for proteins with either high glycine-tyrosine or high sulfur
amino acid content. They displayed putative polyadenylation signals
within a region ~400 bp downstream of their stop codon and nearly all
of them contained a presumptive TATAA box sequence within 100 bp
upstream of the initiation codon. In addition, a variety of both high
glycine-tyrosine and high sulfur KAP pseudogenes (see Table
II) were identified by either the absence
of an in-frame initiation codon in the region of homology or by the
occurrence of frame shifts in the respective homology regions. As a
rule, the genes were small (less than 1 kb in size) and comprised only
one exon. The intragenic distances between the KAP genes varied widely
from ~5-100 kb, and in general, the genes possessed no unique
direction of transcription. The entire gene domain could be subdivided
into one large group of 8 high sulfur KAP genes/pseudogene on one end,
followed by a central group of 24 high glycine-tyrosine KAP
genes/pseudogenes and ending thereafter with one high sulfur KAP gene
(see Fig. 1). No putative KAP genes could be found on the DNA sequences
immediately adjacent to this domain, but the presence of a further
potential high sulfur KAP gene domain, the one initially identified
during the sequencing of chromosome 21 (33), was
confirmed.2

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Physical map of the KAP gene domain.
Black horizontal lines represent the relevant
portions of the Human Genome Project DNA sequences AP001708 and
AP001709 (33). Vertical red bars indicate high sulfur KAP
genes; green bars indicate high glycine-tyrosine KAP genes;
white bars show KAP pseudogenes. Horizontal black
arrowheads indicate the direction of gene transcription. The
numbers below the vertical bars indicate the name
of the respective KAP gene (for example 8.1 = KAP8.1).
before a number indicates a KAP pseudogene.
|
|
Characterization of the High Glycine-Tyrosine and High Sulfur
KAPs--
The KAP genes listed in Fig. 1 were translated into amino
acid sequences followed by a multialignment of the various KAP
proteins. Included into these multiple sequence comparisons were both
high glycine-tyrosine and high sulfur KAP proteins from other species, which had already been appointed to distinct KAP families or were found
in the literature without special classification. This allowed the
creation of an evolutionary tree in which human and non-human KAP
proteins were grouped into distinct families (Fig.
2). In addition to the human orthologs of
six previously described KAP families (KAP6, KAP7, KAP8, KAP11, KAP13,
KAP15), we identified six novel KAP families, four high
glycine-tyrosine KAP families (KAP19-KAP22) and one high sulfur KAP
family (KAP23). Human orthologs segregating with the members of the
murine high glycine-tyrosine KAP18 family (36) (see "Discussion")
or the sheep high sulfur KAP10 (2) and mouse KAP12 proteins (10) were
not detected in the evolutionary tree (Fig. 2).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
The grouping of keratin-associated proteins
into families via CLUSTREE analysis. Multiple alignment of
all of the human KAP amino acid sequences presented here with all
relevant KAP sequences from other species were performed using the
CLUSTAL program. Graphic representation of the segregation of KAP
family members was performed using CLUSTREE. The human amino acid
sequences can be found in this paper (Figs. 3-8, see also Table II).
* denotes a KAP gene that did not segregate correctly.
Sequences from other species are named using their accession numbers.
KAPs named in black represent human sequences;
red indicates mouse sequences; blue indicates
sheep sequences; and green indicates rabbit sequences.
CLUSTAL alignment allowed the division of KAP proteins into families,
but was not statistically significant enough to determine paralogous
evolutionary relationships.
|
|
The human high glycine-tyrosine KAPs can be divided into seven
families, three of which are counterparts of KAP families previously described in other species: The KAP6 family with three members, KAP6.1-KAP6.3 (Figs. 2 and 3) and the
hKAP7 and hKAP8 families with one member
each, KAP7.1 and KAP8.1, respectively (Figs. 2, 4, and 5)
(27-29). The KAP6 family members range in size from 6.6 to 11.1 kDa
and exhibit a high content of glycine and tyrosine residues (54.6-60.5
mol %, see Table II). Except for KAP6.3, the completely identified
KAP6 proteins from all species display unique amino-terminal
(MCG(S/-)YY(G/R)NY) and carboxyl-terminal (GS(G/S)FGYY(Y/-)) sequence
motifs (Fig. 3). Both the 9.3-kDa KAP7.1 and the 6.8-kDa KAP8 proteins
not only exhibit a particularly high sequence homology with their
non-human counterparts (Figs. 4 and 5) but also display a particularly
low glycine-tyrosine content (34.4 and 42.8 mol %; Table II). All of
the known KAP8 proteins from various species show a characteristic
carboxyl-terminal amino acid sequence (RR(F/Y)(W/S)PFALY) (Fig. 4).
However, the first nine amino acids of human KAP8.1 are significantly
different from the orthologous mouse and sheep sequences (Fig. 4).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 3.
Multiple sequence alignment of KAP6 family
members. All of the sequences shown are amino acid translations of
the gene sequences (see Table II). Multialignments were performed using
the CLUSTAL program (49). The asterisks beside the protein
names indicate KAP members from other species, which are designated by
their accession numbers. Asterisks below the alignment
indicate sequence identity; dots denote sequence homology.
The sequence names in bold type denote gene products for
which a cDNA has been isolated; KAP members whose expression could
be shown by in situ hybridization are underlined.
M95719 and Gillespie (50) are sheep sequences;
d86419-d86421 and af345298 are mouse sequences;
m95718 is a rabbit KAP sequence.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
Multiple sequence alignment of KAP8 family
members. For details see Fig. 3. x05639,
m28304, p02248, and marshall (41) are
sheep sequences; d86423 is a mouse sequence.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 5.
Multiple sequence alignments of KAP7, KAP20,
KAP21, and KAP22 family members. For details, see Fig. 3.
x05638 is a sheep sequence; d89901,
d89902, and af345297 are mouse sequences.
|
|
KAP19-KAP22 represent new human high glycine-tyrosine KAP families.
The large KAP19 family consists of 7 members, KAP19.1-KAP19.7, whose
size ranges from 5.7 to 9.1 kDa and which exhibit a rather high
glycine-tyrosine content (~55 mol %) (Fig.
6 and Table II). All KAP19 family members
have distinctive amino-terminal (M(S)/M(/R)(Y/H)(Y/S)(G/N)(S/N) YY,
one exception is KAP19.2) and carboxyl-terminal ((F/S)SGFY, one
exception is hKAP19.4) amino acid sequences. Both the KAP20 and the
KAP21 families consist of two members, KAP20.1-KAP20.2 and
KAP21.1-KAP21.2, respectively, while the KAP22 family comprises only
one member, KAP22.1 (Fig. 5).

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 6.
Multiple sequence alignment of KAP19 family
members. For details, see Fig. 3. ay026312,
d86422, af477980 and af345294 are
mouse sequences.
|
|
The KAP20 proteins range in size between 6.2 and 6.9 kDa, show short,
conserved amino-terminal and carboxyl-terminal sequences (M(I/C)YY(R/S)(G/N)YY and RY(W/-)(S/-)(Y/C)GFY) (Fig. 5) and possess the highest glycine-tyrosine content (61.5-67.8 mol %; Table II) of
all high glycine-tyrosine KAPs described here. The KAP21 proteins exhibit sizes between 7.9 and 8.5 kDa and possess a distinctly lower
glycine-tyrosine content of 50.6-53.1 mol % (Table II), as well as
family specific amino- (MCCNYY) and carboxyl-terminal (CYS(S/C)C(Y)/-/(C)) sequences (Fig. 5). Finally, the single KAP22.1 protein is 5.2 kDa in size and exhibits the second lowest
glycine-tyrosine content (37.5 mol %; Table II). All of the high
glycine-tyrosine KAPs show a high degree of dimeric repeat structures,
usually consisting of glycine in the first position followed by either tyrosine, cysteine, serine, or glycine in the second position. The
degree of repetitiveness is highly variable ranging from 10 to 30 repeats for the KAP6 proteins and 3-34 repeats for the KAP8, KAP20,
and KAP21 family members. In contrast, KAP7 and KAP22.1 contain
only few repeat structures.
The high sulfur KAP portion of the gene domain described here contains
four distinct families, three of which, KAP11, KAP13, KAP15, have been
previously characterized in other species (15-17, 20). The largest
high sulfur family is KAP13, which consists of four members,
KAP13.1-KAP13.4 (Fig. 7). The human and
mouse KAP13 proteins range in size from 17.7 to 19.2 kDa, possess
12.0-12.8 mol % cysteine residues (Table II), and contain a family
specific amino-terminal end (M(S/V)Y(N/S)CCS) as well as a high degree of positionally conserved amino acids (cysteine (14), serine (13),
proline (7), glycine (6)). The remaining three human high sulfur KAP
families, KAP11, KAP15 and KAP23, consist of only single members. Both
KAP11.1 and KAP15.1 show a particularly high sequence homology to their
respective mouse orthologs (Figs. 7 and
8) and exhibit 14.1 and 10.9 mol % cysteine residues (Table II). The KAP13 family members (size range
17.7-19.2 kDa) and the single KAP11 member (17.1 kDa) represent the
largest KAPs described here. Finally, the novel KAP23.1 segregates
separately from the other KAP members in the evolutionary tree analysis
(Fig. 2) and was, therefore, assigned a new family (KAP23) (Fig. 8).
KAP23.1 encodes a 6.8-kDa protein that possesses 7.7 mol % cysteine as well as a high mol % of serine (20.0 mol %), glycine (13.8 mol %),
and leucine (13.8 mol %). No obvious repeat structure is present in
this protein.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 7.
Multiple sequence alignments of KAP11 and
KAP13 family members. Repeat structures are boxed. For
details, see Fig. 3. u03686 and af031485 are
mouse sequences.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 8.
Multiple sequence alignments of KAP15 and
KAP23 family members. Repeat structures are boxed. For
further details, see Fig. 3. af162800 is a mouse
sequence.
|
|
The high sulfur KAPs presented here show, like the previously described
human high sulfur KAP1-KAP3 families, cysteine-containing repeat
structures. These structures, however, possess a lower degree of
conservation when compared with the human KAP1-KAP3 families (20). For
example, KAP11.1, like its mouse counterpart (15), exhibits a fairly
strong decapeptide repeat structure covering the carboxyl-terminal half
of the protein (see Fig. 7). The degree of repetitiveness is higher,
however, in the mouse sequence. In a similar manner, mouse KAP13.1
contains a strongly conserved decameric repeat structure containing an
initial CQ(L/E) motif (16), which is only partially seen in the human
KAP13 family members (Fig. 7). Both, however, possess, in addition, generally less well conserved pentameric repeats in their
carboxyterminal regions. A pentameric SL(G/D)CG motif is also seen in
human KAP15.1. In contrast KAP23.1 does not appear to possess an
obvious repeat structure (Fig. 8).
Expression Analyses--
3'-Noncoding region PCR products from all
of the KAP genes presented in this study were used as probes to screen
a previously described arrayed human scalp cDNA library (20). This
led to the isolation of three high glycine-tyrosine (KAP7.1, KAP8.1, and KAP19.1) and two high sulfur (KAP11.1 and KAP13.1) KAP cDNA clones (see Table I). The low number of positive clones isolated, coupled with the identification of a partial KAP6.1 cDNA via
3'-RACE analysis of follicular RNA,2 led us to
believe that most of the KAP genes analyzed possessed an expression
level below the limits of detection in our arrayed cDNA library,
which contains only 26,000 clones. We therefore subcloned all the PCR
products used in the cDNA library screen (Table I) and used them as
cRNA probes for in situ hybridization studies of both
plucked beard hairs and scalp sections. This resulted in the
demonstration of mRNA expression for a total of 17 KAP genes, 11 high glycine-tyrosine, and six high sulfur members (Fig. 9). With the exception of the
KAP7.1 gene, all of the high glycine-tyrosine and high
sulfur KAP genes showed similar degrees of expression in the two hair
types, but the individual expression patterns varied strongly from gene
to gene. The high glycine-tyrosine KAP genes, KAP7.1,
KAP8.1, KAP19.1, KAP19.2 and the high
sulfur KAP gene KAP11.1 exhibited strong expression.
Interestingly, the prominent expression level of KAP7.1 was
limited to scalp follicles, while beard hair follicles showed a
drastically reduced expression pattern (Fig. 9, B and
B'). In contrast, the remaining KAP genes displayed remarkably low levels of expression (Fig. 9). The expression patterns of high glycine-tyrosine KAP genes could be further subdivided. KAP6.1
(Fig. 9A), KAP7.1 (Fig. 9, B and B'),
KAP19.1 (Fig. 9D), and KAP19.2 (Fig. 9E)
transcripts clearly occurred in the upper portion of the hair cortex.
Of these, KAP6.1 and, in particular, KAP19.1 transcripts exhibited a
vertical asymmetry of expression in the cortex. Moreover,
KAP19.1 showed an additional region of expression in the
hair cuticle, occurring nearly simultaneously with the onset of
cortical mRNA expression (Fig. 9D).

View larger version (147K):
[in this window]
[in a new window]
|
Fig. 9.
Regions of mRNA synthesis of high
glycine-tyrosine (A-L) and high sulfur
(M-R) KAP families in plucked beard
(A, B'-I, M-R) and
scalp (B, K-L) hair follicles.
Numbers on the lower right-hand side of
each picture designate the name of each individual KAP family member.
Red arrows, zone of major mRNA synthesis in the cortex;
red dotted angled arrows, zone of mRNA synthesis in the
hair cuticle; co, hair cortex; co*, region of
asymmetric KAP expression in the cortex. Note the heterogeneity of
vertical KAP-mRNA expression in the hair forming compartment.
med, medulla; dp, dermal papillae.
Bars: 150 µm.
|
|
In contrast, the mRNA expression of KAP8.1 (Fig.
9C), KAP19.3 (Fig. 9F),
KAP19.6 (Fig. 9H), KAP19.7 (Fig.
9I), KAP20.1 (Fig. 9K), and
KAP21.2 (Fig. 9L) obviously initiated in the
lower cortex or even in the matrix of the follicle. Several of these
KAP genes also showed cuticular expression. For example,
KAP19.6 and KAP21.2 exhibited an onset of
expression in the upper portion of the cuticle, which occurred much
later than their respective corticular expression. Two of the high
glycine-tyrosine KAP genes (KAP8.1 and KAP19.4) displayed highly remarkable expression patterns. In the first case, the
particularly strong KAP8.1 mRNA expression was essentially restricted to only one vertical half of the hair forming compartment and in beard hairs was clearly absent from the central medulla (Fig.
9C). The absence of medullar expression in beard hair
sections could also be observed for the other KAP genes. In the second case, the expression of KAP19.4 was unique for it only
occurred in the upper portion of the hair cuticle. Cortical expression, if present at all, was extremely weak (Fig. 9G). Finally,
for six high glycine-tyrosine KAP genes (KAP6.2,
KAP6.3, KAP19.5, KAP20.2,
KAP21.1, and KAP22.1), neither cDNA library
screening nor in situ hybridization studies resulted in the
demonstration of their expression in hair follicles.
With the exception of the extraordinary strong
KAP11.1 gene expression in the late matrix and the entire
cortex (Fig. 9M), the expression of the remaining high
sulfur KAP genes in these areas was generally very weak (Fig. 9,
N-R). In a manner similar to several of the high
glycine-tyrosine KAP members, a vertical asymmetry was seen for KAP23.1
transcripts (Fig. 9R). A clear-cut cuticular expression was
detected for KAP13.2 (Fig. 9O),
KAP15.1 (Fig. 9Q), and KAP23.1 (Fig.
9R), whose onset of expression occurred well after the
initiation of the respective cortical expression. Interestingly, the
cuticular expression of KAP13.2 appeared distinctly stronger
than that in the cortex and was thus reminiscent of the expression
pattern of the high glycine-tyrosine KAP19.4 gene (Fig. 9G). The only high sulfur KAP gene for which no expression
in the human hair follicle could be demonstrated was
KAP13.4.
 |
DISCUSSION |
The preliminary identification of a KAP gene cluster on chromosome
21q23 by the Human Genome Sequencing Project (33) led us to
characterize an additional domain on chromosome 21q21.2 in a manner
described recently for the elucidation of a human high/ultra-high
sulfur KAP gene locus on chromosome 17q21.2 (20). Analysis of the
EBI/GenBankTM data base allowed the identification of 24 high glycine-tyrosine and high sulfur KAP genes on the contiguous
genomic sequences AP001708 and AP001709, which are part of chromosome
21q22.1. Like the high/ultra-high sulfur KAP genes on chromosome 17, as well as KAP genes identified in other species (2, 20), all of the KAP
genes present on this locus were small in size (<1 kb) and consisted
of only one exon. Remarkable, however, was the insertion of the high
glycine-tyrosine KAP gene domain into the high sulfur KAP gene domain.
Homology comparison of the human high glycine-tyrosine KAP members with
members from other species led to the division of these KAPs into seven
families. Historically, non-human high glycine-tyrosine KAPs were
divided through biochemical separation techniques into highly
glycine-tyrosine-rich type II members (>60% glycine-tyrosine content)
and a second type I group with a lower glycine-tyrosine content (2,
37). Subsequent sequence homology comparisons in sheep and mouse lead
to the initial establishment of three high glycine-tyrosine families:
the type II KAP6 family and the type I KAP7 and KAP8 families (2, 38).
In the current report, three human KAP6 members and one KAP7 and KAP8
member could be identified based on their amino acid homology to sheep
and mouse KAPs.
Interestingly, to date, four KAP6 members are known in the mouse (29,
36), two of which (d86420 and d86421, see Fig. 3) are completely
identical in their amino acid sequences, while their mRNAs possess
differing 5'- and 3'-noncoding regions. In the case of the KAP8 family,
a total of four members is known in sheep, two of which (p02448 and
x05639, see Fig. 4) vary from each other in only two positions, and
therefore, may be polymorphisms (28, 39-41). All in all, the present
composition of the KAP6 and KAP8 families in humans, mouse, and sheep
clearly suggests a heterogeneity in gene number among different
species. Since humans possess two KAP8 pseudogenes (see Fig.
1), the low number of functional human KAP8 members might be partially
due to a species-specific inactivation of KAP8 genes during
evolution. A similar type of gene loss has been described recently for
the human type I keratin pseudogene
hHaA, which possesses
functional orthologs in the chimpanzee and gorilla (42).
Initially, the gene underlying the single human KAP7.1 protein, which
shows a high sequence identity to a previously described sheep gene
sequence (28), was assumed by us to represent a pseudogene due to a
1-base pair insertion into the corresponding DNA sequence on AP001709
(nucleotides 150,677), which would cause a frameshift within the region
coding for the glycine-tyrosine-rich portion of KAP7.1. However, in the
course of a related study in this laboratory, a KAP7.1 cDNA was
isolated that contained a completely intact open reading frame (results
not shown). Subsequently, cDNA/genomic analyses of four unrelated
individuals by PCR clearly showed that all possessed complete open
reading frames for KAP7.1. In addition, we were able to isolate a
partial KAP7.1 clone from our arrayed human scalp cDNA library (see
Table I) and to successfully perform in situ hybridization
studies on human hair follicles using a 3'-noncoding region of the
hKAP7.1 mRNA as a probe (Fig. 9B). Therefore, either
this gene was inactivated in a minority of the human population, or the
observed KAP7.1 gene frameshift on AP001709 was simply a DNA
sequencing error.
The sequence comparison of the remaining human high glycine-tyrosine
KAPs with hitherto undefined KAPs from other species allowed their
classification into the new high glycine-tyrosine KAP families 19-22.
In this context, the large KAP19 family appears especially interesting
as its six human members co-segregated with two out of ten murine KAPs
(af345294 and af4777980, see Figs. 2 and 6), whose genes were
down-regulated in hair follicles of Hoxc13-overexpressing mice (36).
While two of the remaining eight murine KAPs segregated either with the
KAP6 (af345298; Figs. 2 and 3) or the KAP21 family
(af345297; Figs. 2 and 5), remarkably, the remaining six murine KAPs
clearly built up an individual, hitherto unidentified high
glycine-tyrosine KAP family, termed here the KAP18 family (Fig. 2).
Although a certain degree of similarity exists between the mouse KAP18
members and the human KAP19 members (data not shown), the degree of
divergence seen in Fig. 2 suggests that the murine KAP18 family
represents indeed a family of its own. In a manner similar to the KAP18
family, the single KAP22.1 family member (Fig. 5) has, at present, only
been observed in humans.
It should be emphasized that the analysis of the current working draft
of the human genome has resulted in the identification of only one
further putative high glycine-tyrosine KAP gene sequence outside of the
KAP gene domain characterized here. This putative pseudogene is located
on chromosome 13q14 on BAC clone AL138686 (nt 63432-63717). Therefore,
we believe that the entire set of human high glycine-tyrosine
KAP genes are probably described here.
Remarkably, the genes encoding the seven high glycine-tyrosine rich KAP
families on the contiguous DNA sequences AP001708 and AP001709 are
flanked by genes that code for high sulfur KAP proteins (see Fig. 1).
Amino acid homology comparisons of the seven high sulfur KAPs led to
their division into four individual families (KAP11, KAP13, KAP15, and
KAP23), three of which possess counterparts described in other species.
The largest family, KAP13, consists of four members that show a high
sequence homology to the murine KAP13.1, originally designated 4C32
(16). The three remaining human high sulfur KAP families comprise only
single members. Based on amino acid homology, the human KAP11.1 appears to be the ortholog of a mouse KAP protein, originally termed hacl-1, identified accidentally in the search for the
06-methylguanidine-DNA methyltransferase
cDNA (15). Most probably, the single human high sulfur KAP15.1
protein represents the ortholog of mouse KAP15.1 (Fig. 8), one of two
related KAP proteins initially termed pmg1 and pmg2 (17), but renamed
recently mKAP14.2 and mKAP15.1, respectively (see Ref. 20 for
explanation), with which it co-segregates in the CLUSTREE analysis
(Fig. 1). It has recently been shown that the mouse KAP14.2
and KAP15.1 genes are adjacent to each other and possess
opposite directions of transcription (17). Interestingly, upstream of
the human KAP15.1 gene is a putative KAP pseudogene
designated
KAP13A, which exhibits a fairly high homology
with both mKAP14.2 and also the adjacent human
KAP13 genes (Fig. 1 and results not shown). This was
confirmed by a further genome wide BLASTN search with the
mKAP14.2 sequence, which revealed roughly comparable
sequence homologies only with the
KAP13A,
hKAP15.1, and the hKAP13 genes. In addition, the human
KAP13A and KAP15.1 genes/pseudogenes
exhibit, like the mKAP14.2 and mKAP15.1 genes,
different directions of transcription (Ref. 17 and Fig. 1). It is
therefore tempting to speculate that
KAP13A might
represent an orthologous, but inactive, form of mKAP14.2,
and the absence of further orthologs of the mK14.1 gene in
the human genome data base would point to hKAP15.1 as being
the only functional human ortholog of the murine
KAP14.2/KAP15.1 domain.
Chromosome 21 sequencing and its initial gene analysis by bioinformatic
methods identified a surprisingly low number of 225 putative gene and
98 pseudogene loci (33). Recently, these findings have been challenged
in two articles that used combinations of gene prediction and mRNA
expression analysis to show, in one case, that the number of putative
genes on this chromosome may be up to 10-fold higher (43, 44). Our data
support this assumption, for in the chromosome 21 sequencing paper,
only two exons were found by gene prediction analysis on the domain
described here. As such, further biochemical and molecular biological
analysis of the Human Genome Programs bioinformatically generated gene prediction data appears necessary.
In general, the expression characteristics of the human high
glycine-tyrosine and high sulfur KAP genes described here correspond fairly well to what has been previously found in other species. It was
known from earlier protein studies that the follicular expression of
high glycine-tyrosine KAPs varies considerably, being very weak in
human hairs, but strong in sheep wool and mouse hairs (45). This is in
line with our finding that only cDNA clones of the most strongly
expressed high glycine-tyrosine KAP members 7.1, 8.1, and 19.1 (Fig. 9)
resulted from the scalp cDNA library screening (Table I). Moreover,
previous in situ hybridization studies of KAP6 family
members in mouse, rabbit, and sheep have shown that also their
expression occurs preferentially in the upper portion of the hair and
wool cortex (27, 29). This was also true for murine KAP8 family members
(29), while human and sheep KAP8 expression begins much earlier in the
matrix region (Ref. 2 and Fig. 9C). Whereas in sheep and
humans, the cortical expression of KAP6 and KAP8 family members is
vertically compartmentalized (Refs. 2 and 27 and Fig. 9, A
and C)), this is not the case for mouse KAP6 and KAP8
members, which clearly exhibit an even cortical expression (29).
In mice, in situ hybridization studies of individual high
glycine-tyrosine KAP19 (d86422 in Fig. 6), KAP20
(d88901 in Fig. 5) and KAP21 (d89902 in Fig. 5)
members have shown that their expression was limited to the upper
portion of the murine hair cortex (29) and, thus, corresponded to that
of the human KAP19.1, KAP19.2, and
KAP20.1 genes (Fig. 9, D, E, and
K), however, deviated from human KAP21.2, whose
expression initiated further down in the hair matrix (Fig.
9L). Surprising and at present unexplainable was the
striking difference seen in the expression of KAP7.1 in scalp and beard hair follicles (Fig. 9, B and B')
as well as the unique cuticular KAP19.4 expression compared
with the cortical expression pattern of the other KAP19 members.
The majority of the high sulfur KAP genes analyzed in this study show a
generalized mRNA expression in the upper matrix and the entire hair
cortex, with KAP13.2, KAP15.1, and
KAP23.1 also exhibiting cuticular expression. The strongly
expressed KAP11.1 displays a nearly identical expression as
its mouse ortholog (15). The demonstration of cortical
KAP13.1-KAP13.3 expression in the human hair follicle was
surprising, for no such expression has been previously reported in mice
(16). Instead, mouse KAP13.1 was found in the periderm of embryonic
mice as well as the filiform tongue papillae and the parakeratotic tail
epidermis of adult mice (16). To date, the analysis of
KAP13.1-KAP13.3 gene expression in human tongue and
periderm epithelium has been hampered by the unavailability of the
tissue. The weak expression of the human KAP15.1 gene in the
matrix, cortex, and cuticle of the hair follicle (Fig. 9Q)
has not yet been confirmed for its animal orthologs, although a
specific mouse KAP15.1 antibody is available, which has, however, only
been used in Western blots to demonstrate mKAP15.1 in mouse mammary
glands and epidermis (17).
The low mRNA expression of many members of the KAP families
presented here leads to questions concerning the synthesis of their
respective proteins. This is especially important, for data derived
from recent large scale mRNA/protein studies in yeast and human
liver show only a moderate correlation between mRNA transcript and
protein expression (46-48). This appears especially true for genes
with low mRNA expression, for, in one study, mRNA transcripts
with similar degrees of mRNA expression exhibited over 30-fold
differences in protein expression (47). As such the mRNA expression
data described here are no guarantee for concomitant protein
expression. A detailed analysis of the KAP protein expression described
here would go beyond the bounds of this paper, but will be a
challenging task. For example, high glycine/tyrosine KAPs, due to their
strong amino acid conservation and hydrophobic nature, are poorly
amenable to the production of both pan- and individual antiodies. The small size of these proteins (<10 kDa) makes
two-dimensional protein separation difficult, especially in a system
that is amenable to Western blot analysis. If these handicaps can be
overcome, then future analysis, possibly using mass spectrometry
(matrix-assisted laser desorption ionization time-of-flight,
MALDI-TOF) for protein identification, could lead to a final
elucidation of KAP protein expression in the hair follicle.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Herbert Spring (German Cancer
Research Center) for support with confocal microscopy. The cDNA
clones isolated in this study can be obtained from the German Human
Genome Resource Center (RZPD) using the names provided in Table I. We
also thank the RZPD members for continuing support. We also thank Dr.
Alexander Awgulewitsch (Medical University of Charleston, Charleston,
SC) for providing a previously unpublished mouse KAP 18 cDNA sequence.
 |
FOOTNOTES |
*
This work was also supported in part by the Deutsche
Forschungsgemeinschaft (Grant Schw 539/4-1).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ457063, AJ457064, AJ457065, AK457066, and AK457067.
§
These authors contributed equally to this work.
¶
To whom correspondence should be addressed: Section of
Normal and Neoplastic Epidermal Differentiation (B0501), German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Tel.: 49-6221-423248; Fax: 49-6221-424406; E-mail:
m.rogers@dkfz-heidelberg.de.
Published, JBC Papers in Press, September 30, 2002, DOI 10.1074/jbc.M206422200
2
M. A. Rogers, L. Langbein, H. Winter, C. Ehmann, S. Praetzel, and J. Schweizer, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
KAP, keratin-associated protein;
ISH, in situ
hybridization.
 |
REFERENCES |
| 1.
|
Stenn, K. S.,
and Paus, R.
(2001)
Physiol. Rev.
81,
449-494[Abstract/Free Full Text]
|
| 2.
|
Powell, B. C.,
and Rogers, G. E.
(1997)
in
Formation and Structure of Human Hair
(Jolles, P.
, Zahn, H.
, and Höcker, H., eds)
, pp. 59-148, Birkhäuser Verlag, Basel, Switzerland
|
| 3.
|
Fuchs, E.,
and Weber, K.
(1994)
in
Annual Review of Biochemistry
(Richardson, C. C., ed)
, pp. 345-382, Annual Reviews Inc., Palo Alto, CA
|
| 4.
|
Steinert, P. M.,
and Roop, D. R.
(1988)
Annu. Rev. Biochem.
57,
593-625[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Rogers, M. A.,
Winter, H.,
Langbein, L.,
Wolf, C.,
and Schweizer, J.
(2000)
J. Invest. Dermatol.
114,
464-472[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Rogers, M. A.,
Winter, H.,
Wolf, C.,
Heck, M.,
and Schweizer, J.
(1998)
J. Biol. Chem.
273,
26683-26691[Abstract/Free Full Text]
|
| 7.
|
Langbein, L.,
Rogers, M. A.,
Winter, H.,
Praetzel, S.,
and Schweizer, J.
(2001)
J. Biol. Chem.
276,
35123-35132[Abstract/Free Full Text]
|
| 8.
|
Langbein, L.,
Rogers, M. A.,
Winter, H.,
Praetzel, S.,
Beckhaus, U.,
Rackwitz, H.-R.,
and Schweizer, J.
(1999)
J. Biol. Chem.
274,
19874-19884[Abstract/Free Full Text]
|
| 9.
|
Zhumbaeva, B. D.,
Gening, L. V.,
and Gazaryan, K. G.
(1992)
Mol. Biol.
26,
550-555
|
| 10.
|
Cole, S. E.,
and Reeves, R. H.
(1998)
Genomics
54,
437-442[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Swart, L. S.,
Joubert, F. J.,
and Parris, D.
(1976)
in
Proceedings of the Fifth International Wool Textile Research Conference
(Ziegler, K., ed)
, pp. 254-264, German Wool Research Institute, Aachen, Germany
|
| 12.
|
Mitsui, S.,
Ohuchi, A.,
Adachi-Yamada, T.,
Hotta, M.,
Tsuboi, R.,
and Ogawa, H.
(1998)
Gene (Amst.)
208,
123-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Powell, B. C.,
Sleigh, M. J.,
Ward, K. A.,
and Rogers, G. E.
(1983)
Nucleic Acids Res.
11,
5327-5346[Abstract/Free Full Text]
|
| 14.
|
Frenkel, M. J.,
Powell, B. C.,
Ward, K. A.,
Sleigh, M. J.,
and Rogers, G. E.
(1989)
Genomics
4,
182-191[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Huh, N.,
Kashiwagi, M.,
Konishi, C.,
Hashimoto, Y.,
Kohno, Y.,
Nomura, S.,
and Kuroki, T.
(1994)
J. Invest. Dermatol.
102,
716-720[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Takaishi, M.,
Takata, Y.,
Kuroki, T.,
and Huh, N.-H.
(1998)
J. Invest. Dermatol.
111,
128-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Kuhn, F.,
Lassing, C.,
Rang, A.,
Mueller, M.,
Hunziker, T.,
Ziemiecki, A.,
and Andres, A.-C.
(1999)
Mech. Dev.
86,
193-196[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Aoki, N.,
Ito, K.,
and Ito, M.
(1998)
J. Invest. Dermatol.
111,
804-809[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Swart, L. S.,
and Haylett, T.
(1973)
Biochem. J.
133,
641-654[Medline]
[Order article via Infotrieve]
|
| 20.
|
Rogers, M. A.,
Langbein, L.,
Winter, H.,
Ehmann, C.,
Praetzel, S.,
Korn, B.,
and Schweizer, J.
(2001)
J. Biol. Chem.
276,
19440-19451[Abstract/Free Full Text]
|
| 21.
|
Powell, B. C.,
Arthur, J.,
and Nesci, A.
(1995)
Differentiation
58,
227-232[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Fratini, A.,
Powell, B. C.,
Hynd, P. I.,
Keough, R. A.,
and Rogers, G. E.
(1994)
J. Invest. Dermatol.
102,
178-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Perez, C.,
Auriol, J.,
Gerst, C.,
Bernard, B. A.,
and Egly, J. M.
(1999)
Gene (Amst.)
227,
137-148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
MacKinnon, P. J.,
Powell, B. C.,
and Rogers, G. E.
(1990)
J. Cell Biol.
111,
2587-2600[Abstract/Free Full Text]
|
| 25.
|
McNab, A. R.,
Andrus, P.,
Wagner, T. E.,
Buhl, A. E.,
Waldon, D. J.,
Kawabe, T. T.,
Rae, T. J.,
Groppi, V.,
and Vogeli, G.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
6848-6852[Abstract/Free Full Text]
|
| 26.
|
Jenkins, B. J.,
and Powell, B. C.
(1994)
J. Invest. Dermatol.
103,
310-317[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Fratini, A.,
Powell, B. C.,
and Rogers, G. E.
(1993)
J. Biol. Chem.
268,
4511-4518[Abstract/Free Full Text]
|
| 28.
|
Kuczek, E. S.,
and Rogers, G. E.
(1987)
Eur. J. Biochem.
166,
79-85[Medline]
[Order article via Infotrieve]
|
| 29.
|
Aoki, N.,
and Ito, M.
(1997)
J. Biol. Chem.
272,
30512-30518[Abstract/Free Full Text]
|
| 30.
|
Gillespie, J. M.
(1991)
in
Physiology, Biochemistry and Molecular Biology of the Skin
(Goldsmith, L. A., ed)
, pp. 625-659, Oxford University Press, Oxford
|
| 31.
|
Shimomura, Y.,
Aoki, N.,
Rogers, M. A.,
Langbein, L.,
Schweizer, J.,
and Ito, M.
(2002)
J. Invest. Dermatol.
118,
226-231[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
MacKinnon, P. J.,
Powell, B. C.,
Rogers, G. E.,
Baker, E. G.,
MacKinnon, R. N.,
Hyland, V. J.,
Callen, D. F.,
and Sutherland, G. R.
(1991)
Mamm. Genome
1,
53-56[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Hattori, M.,
Fujiyama, A.,
Taylor, T. D.,
Watanabe, H.,
Yada, T.,
Park, H. S.,
Toyoda, A.,
Ishii, K.,
Totoki, Y.,
Choi, D. K.,
Soeda, E.,
Ohki, M.,
Takagi, T.,
Sakaki, Y.,
Taudien, S.,
Blechschmidt, K.,
Polley, A.,
Menzel, U.,
Delabar, J.,
Kumpf, K.,
Lehmann, R.,
Patterson, D.,
Reichwald, K.,
Rump, A.,
Schillhabel, M.,
and Schudy, A.
(2000)
Nature
405,
311-319[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Langbein, L.,
Heid, H. W.,
Moll, I.,
and Franke, W. W.
(1994)
Differentiation
55,
57-71
|
| 35.
|
Rogers, M. A.,
Langbein, L.,
Praetzel, S.,
Moll, I.,
Krieg, T.,
Winter, H.,
and Schweizer, J.
(1997)
Differentiation
61,
187-194[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Tkatchenko, A. V.,
Visconti, R. P.,
Shang, L.,
Papenbrock, T.,
Pruett, N. D.,
Ito, T.,
Ogawa, M.,
and Awgulewitsch, A.
(2001)
Development (Camb.)
128,
1547-1558[Abstract]
|
| 37.
|
Gillespie, J. M.
(1983)
in
Biochemistry and Physiology of the Skin
(Goldsmith, L. A., ed)
, pp. 475-510, Oxford University Press, Oxford
|
| 38.
|
Rogers, G. E.,
and Powell, B. C.
(1993)
J. Invest. Dermatol.
101,
50s-55s[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Dopheide, T. A.
(1973)
Eur. J. Biochem.
34,
120-124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kuczek, E.,
and Rogers, G. E.
(1985)
Eur. J. Biochem.
146,
89-93[Medline]
[Order article via Infotrieve]
|
| 41.
|
Marshall, R. C.,
Gillespie, J. M.,
Inglis, A. S.,
and Frenkel, M. J.
(1980)
in
Proceedings of the Sixth International Wool Textile Research Conference
(Ziegler, K., ed)
, pp. 147-158, German Wool Research Institute, Aachen, Germany
|
| 42.
|
Winter, H.,
Langbein, L.,
Krawczak, M.,
Cooper, D. N.,
Jave-Suarez, L. F.,
Rogers, M. A.,
Praetzel, S.,
Heidt, P. J.,
and Schweizer, J.
(2001)
Hum. Genet.
108,
37-42[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Reymond, A.,
Camargo, A. A.,
Deutsch, S.,
Stevenson, B. J.,
Parmigiani, R. B.,
Ucla, C.,
Bettoni, F.,
Rossier, C.,
Lyle, R.,
Guipponi, M.,
de Souza, S.,
Iseli, C.,
Jongeneel, C. V.,
Bucher, P.,
Simpson, A. J.,
and Antonarakis, S. E.
(2002)
Genomics
79,
824-832[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Kapranov, P.,
Cawley, S. E.,
Drenkow, J.,
Bekiranov, S.,
Strausberg, R. L.,
Fodor, S. P.,
and Gingeras, T. R.
(2002)
Science
296,
916-919[Abstract/Free Full Text]
|
| 45.
|
Gillespie, J. M.
(1972)
Comp. Biochem. Physiol. B
41,
723-734[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Miklos, G. L.,
and Maleszka, R.
(2001)
Proteomics
1,
169-178[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Gygi, S. P.,
Rochon, Y.,
Franza, B. R.,
and Aebersold, R.
(1999)
Mol. Cell. Biol.
19,
1720-1730[Abstract/Free Full Text]
|
| 48.
|
Anderson, L.,
and Seilhamer, J.
(1997)
Electrophoresis
18,
533-537[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Higgins, D. G.,
Thompson, J. D.,
and Gibson, T. J.
(2000)
Methods Enyzmol.
266,
383-402
|
| 50.
|
Gillespie, J. M.
(1990)
in
Cellular and Molecular Biology of Intermediate Filaments
(Goldman, R. D.
, and Steinert, P. M., eds)
, pp. 95-128, Plenum Press, New York
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. D. Pruett, T. V. Tkatchenko, L. Jave-Suarez, D. F. Jacobs, C. S. Potter, A. V. Tkatchenko, J. Schweizer, and A. Awgulewitsch
Krtap16, Characterization of a New Hair Keratin-associated Protein (KAP) Gene Complex on Mouse Chromosome 16 and Evidence for Regulation by Hoxc13
J. Biol. Chem.,
December 3, 2004;
279(49):
51524 - 51533.
[Abstract]
[Full Text]
[PDF]
|
 |
|